

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.91282074 |
| 2 | muscle atrophy (GO:0014889) | 4.83013352 |
| 3 | cellular response to interleukin-15 (GO:0071350) | 4.63366253 |
| 4 | striated muscle atrophy (GO:0014891) | 4.62780595 |
| 5 | skeletal muscle adaptation (GO:0043501) | 4.46638956 |
| 6 | regulation of germinal center formation (GO:0002634) | 4.23037413 |
| 7 | L-fucose catabolic process (GO:0042355) | 4.13409156 |
| 8 | fucose catabolic process (GO:0019317) | 4.13409156 |
| 9 | L-fucose metabolic process (GO:0042354) | 4.13409156 |
| 10 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 4.08507024 |
| 11 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.01803435 |
| 12 | DNA double-strand break processing (GO:0000729) | 3.88392868 |
| 13 | protein polyglutamylation (GO:0018095) | 3.86638394 |
| 14 | response to interleukin-15 (GO:0070672) | 3.76398732 |
| 15 | response to xenobiotic stimulus (GO:0009410) | 3.74418795 |
| 16 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.63763506 |
| 17 | regulation of skeletal muscle contraction (GO:0014819) | 3.56847810 |
| 18 | sulfation (GO:0051923) | 3.55919553 |
| 19 | interferon-gamma production (GO:0032609) | 3.51100332 |
| 20 | adaptation of signaling pathway (GO:0023058) | 3.46061577 |
| 21 | lymph node development (GO:0048535) | 3.36121151 |
| 22 | DNA demethylation (GO:0080111) | 3.35211883 |
| 23 | cytidine metabolic process (GO:0046087) | 3.34707295 |
| 24 | cytidine catabolic process (GO:0006216) | 3.34707295 |
| 25 | cytidine deamination (GO:0009972) | 3.34707295 |
| 26 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.31922322 |
| 27 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 3.31773161 |
| 28 | regulation of sarcomere organization (GO:0060297) | 3.26930221 |
| 29 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 3.26901240 |
| 30 | activated T cell proliferation (GO:0050798) | 3.26580697 |
| 31 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.25663051 |
| 32 | response to pheromone (GO:0019236) | 3.25249437 |
| 33 | tryptophan metabolic process (GO:0006568) | 3.23436601 |
| 34 | natural killer cell differentiation (GO:0001779) | 3.22664008 |
| 35 | regulation of DNA endoreduplication (GO:0032875) | 3.19833543 |
| 36 | multicellular organism reproduction (GO:0032504) | 3.18454915 |
| 37 | negative regulation by host of viral transcription (GO:0043922) | 3.18054222 |
| 38 | positive regulation of defense response to virus by host (GO:0002230) | 3.14715112 |
| 39 | DNA dealkylation (GO:0035510) | 3.12686551 |
| 40 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.06313764 |
| 41 | neural tube formation (GO:0001841) | 3.04106894 |
| 42 | heme transport (GO:0015886) | 3.01253107 |
| 43 | regulation of natural killer cell differentiation (GO:0032823) | 2.97692445 |
| 44 | hepatocyte apoptotic process (GO:0097284) | 2.96742948 |
| 45 | natural killer cell activation (GO:0030101) | 2.96658675 |
| 46 | regulation of fibroblast apoptotic process (GO:2000269) | 2.96357551 |
| 47 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.94452448 |
| 48 | DNA deamination (GO:0045006) | 2.93642096 |
| 49 | positive regulation of T cell chemotaxis (GO:0010820) | 2.93445527 |
| 50 | regulation of T cell chemotaxis (GO:0010819) | 2.93445527 |
| 51 | positive regulation of macrophage differentiation (GO:0045651) | 2.91483497 |
| 52 | T cell migration (GO:0072678) | 2.88734224 |
| 53 | dentate gyrus development (GO:0021542) | 2.88376609 |
| 54 | positive regulation of natural killer cell activation (GO:0032816) | 2.87264700 |
| 55 | protein K63-linked deubiquitination (GO:0070536) | 2.82645920 |
| 56 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.77470729 |
| 57 | positive regulation of developmental pigmentation (GO:0048087) | 2.77406569 |
| 58 | regulation of hippo signaling (GO:0035330) | 2.74195501 |
| 59 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.73836684 |
| 60 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.72831276 |
| 61 | regulation of defense response to virus by host (GO:0050691) | 2.72296977 |
| 62 | phospholipid translocation (GO:0045332) | 2.72066868 |
| 63 | lipid translocation (GO:0034204) | 2.72066868 |
| 64 | cellular response to ethanol (GO:0071361) | 2.71805752 |
| 65 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 2.65556616 |
| 66 | protein K11-linked deubiquitination (GO:0035871) | 2.65187365 |
| 67 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.64939217 |
| 68 | establishment of protein localization to Golgi (GO:0072600) | 2.63872653 |
| 69 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.61457081 |
| 70 | indolalkylamine metabolic process (GO:0006586) | 2.60332964 |
| 71 | arginine catabolic process (GO:0006527) | 2.59973937 |
| 72 | regulation of natural killer cell activation (GO:0032814) | 2.59302999 |
| 73 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.57789961 |
| 74 | negative regulation of cell killing (GO:0031342) | 2.57789961 |
| 75 | positive regulation of interleukin-17 production (GO:0032740) | 2.57210587 |
| 76 | synapsis (GO:0007129) | 2.55060557 |
| 77 | negative regulation of T cell apoptotic process (GO:0070233) | 2.53732343 |
| 78 | indole-containing compound catabolic process (GO:0042436) | 2.53483556 |
| 79 | indolalkylamine catabolic process (GO:0046218) | 2.53483556 |
| 80 | tryptophan catabolic process (GO:0006569) | 2.53483556 |
| 81 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.52784317 |
| 82 | protein targeting to Golgi (GO:0000042) | 2.50207997 |
| 83 | histone H2A acetylation (GO:0043968) | 2.49937705 |
| 84 | replication fork processing (GO:0031297) | 2.48741988 |
| 85 | B cell homeostasis (GO:0001782) | 2.45053099 |
| 86 | regulation of regulatory T cell differentiation (GO:0045589) | 2.45048628 |
| 87 | negative T cell selection (GO:0043383) | 2.43630577 |
| 88 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 2.42536941 |
| 89 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.42099366 |
| 90 | T cell mediated immunity (GO:0002456) | 2.41279698 |
| 91 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.39525085 |
| 92 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.38462625 |
| 93 | protein K48-linked deubiquitination (GO:0071108) | 2.38178139 |
| 94 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.38132512 |
| 95 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.35470548 |
| 96 | negative regulation of DNA binding (GO:0043392) | 2.35247207 |
| 97 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.34290338 |
| 98 | auditory receptor cell differentiation (GO:0042491) | 2.34142629 |
| 99 | T cell proliferation (GO:0042098) | 2.34048718 |
| 100 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.33029710 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.21810260 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.15306656 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.84453784 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.77755912 |
| 5 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.46198698 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.35955700 |
| 7 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.76728024 |
| 8 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.76079518 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.68808196 |
| 10 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.62988016 |
| 11 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.48612511 |
| 12 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.28393016 |
| 13 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.20316416 |
| 14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.12371027 |
| 15 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.11133189 |
| 16 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.06723550 |
| 17 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.01458190 |
| 18 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.94574928 |
| 19 | EWS_26573619_Chip-Seq_HEK293_Human | 1.92976312 |
| 20 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.85620755 |
| 21 | P300_19829295_ChIP-Seq_ESCs_Human | 1.80884012 |
| 22 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.78162064 |
| 23 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.73326614 |
| 24 | FUS_26573619_Chip-Seq_HEK293_Human | 1.64967094 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.63506703 |
| 26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.63501750 |
| 27 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.63295760 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.60625835 |
| 29 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.58861756 |
| 30 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.56263451 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.54885734 |
| 32 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.53532427 |
| 33 | STAT3_23295773_ChIP-Seq_U87_Human | 1.48961570 |
| 34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.47753489 |
| 35 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.44651367 |
| 36 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.42077162 |
| 37 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.42077162 |
| 38 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.41714687 |
| 39 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.41714687 |
| 40 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.37219618 |
| 41 | RXR_22108803_ChIP-Seq_LS180_Human | 1.36685721 |
| 42 | MYB_26560356_Chip-Seq_TH2_Human | 1.35584156 |
| 43 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.32615177 |
| 44 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.32603380 |
| 45 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.31893741 |
| 46 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.30711595 |
| 47 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.29176828 |
| 48 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.28833722 |
| 49 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.27054017 |
| 50 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.26847649 |
| 51 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.26802272 |
| 52 | GATA3_26560356_Chip-Seq_TH2_Human | 1.26733468 |
| 53 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.25811468 |
| 54 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.25076684 |
| 55 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23760172 |
| 56 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.22883310 |
| 57 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.20756402 |
| 58 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.18959949 |
| 59 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.18293447 |
| 60 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17614945 |
| 61 | VDR_22108803_ChIP-Seq_LS180_Human | 1.17193134 |
| 62 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.17186547 |
| 63 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.16384183 |
| 64 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.15952043 |
| 65 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.15899320 |
| 66 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.15845695 |
| 67 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.13358329 |
| 68 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.13324174 |
| 69 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.13171840 |
| 70 | TCF4_23295773_ChIP-Seq_U87_Human | 1.12805192 |
| 71 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.10091265 |
| 72 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.09795772 |
| 73 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.09560567 |
| 74 | MYB_26560356_Chip-Seq_TH1_Human | 1.07973928 |
| 75 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.07288332 |
| 76 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.07017934 |
| 77 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.06127720 |
| 78 | TP53_16413492_ChIP-PET_HCT116_Human | 1.06098306 |
| 79 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.04080908 |
| 80 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03142614 |
| 81 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02659358 |
| 82 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.02328154 |
| 83 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.00283751 |
| 84 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.99713511 |
| 85 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.99713511 |
| 86 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.99410154 |
| 87 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.98003334 |
| 88 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.97978070 |
| 89 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97841109 |
| 90 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97455721 |
| 91 | AR_25329375_ChIP-Seq_VCAP_Human | 0.96282395 |
| 92 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.96007952 |
| 93 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.95924042 |
| 94 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95399402 |
| 95 | GATA3_26560356_Chip-Seq_TH1_Human | 0.94532314 |
| 96 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.94376045 |
| 97 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.91682216 |
| 98 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.89912111 |
| 99 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.88406834 |
| 100 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.87360736 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004147_increased_porphyrin_level | 4.33946206 |
| 2 | MP0000569_abnormal_digit_pigmentation | 3.29392025 |
| 3 | MP0003656_abnormal_erythrocyte_physiolo | 3.21421958 |
| 4 | MP0006072_abnormal_retinal_apoptosis | 3.18120225 |
| 5 | MP0000372_irregular_coat_pigmentation | 3.09674884 |
| 6 | MP0008995_early_reproductive_senescence | 2.82008106 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 2.79976624 |
| 8 | MP0004381_abnormal_hair_follicle | 2.69714999 |
| 9 | MP0003136_yellow_coat_color | 2.66554713 |
| 10 | MP0005671_abnormal_response_to | 2.59401273 |
| 11 | MP0003786_premature_aging | 2.50118636 |
| 12 | MP0003763_abnormal_thymus_physiology | 2.05058161 |
| 13 | MP0000465_gastrointestinal_hemorrhage | 1.98807512 |
| 14 | MP0008057_abnormal_DNA_replication | 1.89564000 |
| 15 | MP0005253_abnormal_eye_physiology | 1.85978313 |
| 16 | MP0005171_absent_coat_pigmentation | 1.83656476 |
| 17 | MP0006054_spinal_hemorrhage | 1.78659254 |
| 18 | MP0000685_abnormal_immune_system | 1.77358673 |
| 19 | MP0009697_abnormal_copulation | 1.75750405 |
| 20 | MP0003045_fibrosis | 1.71346051 |
| 21 | MP0005389_reproductive_system_phenotype | 1.66644077 |
| 22 | MP0005075_abnormal_melanosome_morpholog | 1.65350332 |
| 23 | MP0001529_abnormal_vocalization | 1.63376584 |
| 24 | MP0001835_abnormal_antigen_presentation | 1.62225079 |
| 25 | MP0003724_increased_susceptibility_to | 1.62136009 |
| 26 | MP0005377_hearing/vestibular/ear_phenot | 1.60616672 |
| 27 | MP0003878_abnormal_ear_physiology | 1.60616672 |
| 28 | MP0002160_abnormal_reproductive_system | 1.52203993 |
| 29 | MP0002095_abnormal_skin_pigmentation | 1.51037791 |
| 30 | MP0008789_abnormal_olfactory_epithelium | 1.50007872 |
| 31 | MP0000749_muscle_degeneration | 1.46456373 |
| 32 | MP0001800_abnormal_humoral_immune | 1.43306102 |
| 33 | MP0004145_abnormal_muscle_electrophysio | 1.41359152 |
| 34 | MP0005551_abnormal_eye_electrophysiolog | 1.40857307 |
| 35 | MP0002405_respiratory_system_inflammati | 1.37555529 |
| 36 | MP0001485_abnormal_pinna_reflex | 1.35668020 |
| 37 | MP0001919_abnormal_reproductive_system | 1.35543516 |
| 38 | MP0001188_hyperpigmentation | 1.35390656 |
| 39 | MP0001879_abnormal_lymphatic_vessel | 1.34362806 |
| 40 | MP0002638_abnormal_pupillary_reflex | 1.30058393 |
| 41 | MP0003195_calcinosis | 1.28621087 |
| 42 | MP0009785_altered_susceptibility_to | 1.28602418 |
| 43 | MP0005310_abnormal_salivary_gland | 1.26271224 |
| 44 | MP0000613_abnormal_salivary_gland | 1.25699364 |
| 45 | MP0004484_altered_response_of | 1.23152542 |
| 46 | MP0000703_abnormal_thymus_morphology | 1.21082444 |
| 47 | MP0002090_abnormal_vision | 1.19826027 |
| 48 | MP0002722_abnormal_immune_system | 1.19400095 |
| 49 | MP0000689_abnormal_spleen_morphology | 1.12879022 |
| 50 | MP0003252_abnormal_bile_duct | 1.10942008 |
| 51 | MP0000427_abnormal_hair_cycle | 1.09180106 |
| 52 | MP0001502_abnormal_circadian_rhythm | 1.09155978 |
| 53 | MP0003221_abnormal_cardiomyocyte_apopto | 1.08845442 |
| 54 | MP0008961_abnormal_basal_metabolism | 1.07912389 |
| 55 | MP0001984_abnormal_olfaction | 1.07855976 |
| 56 | MP0002420_abnormal_adaptive_immunity | 1.07580152 |
| 57 | MP0001819_abnormal_immune_cell | 1.07429539 |
| 58 | MP0003646_muscle_fatigue | 1.03363441 |
| 59 | MP0002127_abnormal_cardiovascular_syste | 1.02416972 |
| 60 | MP0002168_other_aberrant_phenotype | 1.01544989 |
| 61 | MP0000049_abnormal_middle_ear | 1.00621016 |
| 62 | MP0002723_abnormal_immune_serum | 1.00126915 |
| 63 | MP0005499_abnormal_olfactory_system | 0.99988078 |
| 64 | MP0005394_taste/olfaction_phenotype | 0.99988078 |
| 65 | MP0002398_abnormal_bone_marrow | 0.97295043 |
| 66 | MP0002148_abnormal_hypersensitivity_rea | 0.97171509 |
| 67 | MP0010386_abnormal_urinary_bladder | 0.95325369 |
| 68 | MP0002269_muscular_atrophy | 0.95151464 |
| 69 | MP0002452_abnormal_antigen_presenting | 0.93928415 |
| 70 | MP0005000_abnormal_immune_tolerance | 0.93725676 |
| 71 | MP0004134_abnormal_chest_morphology | 0.93717106 |
| 72 | MP0001346_abnormal_lacrimal_gland | 0.92019740 |
| 73 | MP0009765_abnormal_xenobiotic_induced | 0.91150330 |
| 74 | MP0008877_abnormal_DNA_methylation | 0.89729563 |
| 75 | MP0010368_abnormal_lymphatic_system | 0.89323350 |
| 76 | MP0000747_muscle_weakness | 0.87543803 |
| 77 | MP0003011_delayed_dark_adaptation | 0.86882882 |
| 78 | MP0005025_abnormal_response_to | 0.86178305 |
| 79 | MP0002837_dystrophic_cardiac_calcinosis | 0.85570650 |
| 80 | MP0005174_abnormal_tail_pigmentation | 0.84882349 |
| 81 | MP0000716_abnormal_immune_system | 0.83904086 |
| 82 | MP0000371_diluted_coat_color | 0.83555714 |
| 83 | MP0002876_abnormal_thyroid_physiology | 0.80753542 |
| 84 | MP0003890_abnormal_embryonic-extraembry | 0.80291947 |
| 85 | MP0002102_abnormal_ear_morphology | 0.79347262 |
| 86 | MP0001873_stomach_inflammation | 0.78581078 |
| 87 | MP0002332_abnormal_exercise_endurance | 0.78134135 |
| 88 | MP0004084_abnormal_cardiac_muscle | 0.77587775 |
| 89 | MP0005387_immune_system_phenotype | 0.75713134 |
| 90 | MP0001790_abnormal_immune_system | 0.75713134 |
| 91 | MP0004215_abnormal_myocardial_fiber | 0.73709047 |
| 92 | MP0005391_vision/eye_phenotype | 0.73692582 |
| 93 | MP0005084_abnormal_gallbladder_morpholo | 0.70290833 |
| 94 | MP0003937_abnormal_limbs/digits/tail_de | 0.70111266 |
| 95 | MP0002419_abnormal_innate_immunity | 0.70042516 |
| 96 | MP0002163_abnormal_gland_morphology | 0.68910756 |
| 97 | MP0005647_abnormal_sex_gland | 0.68577339 |
| 98 | MP0004036_abnormal_muscle_relaxation | 0.67255582 |
| 99 | MP0005187_abnormal_penis_morphology | 0.67131007 |
| 100 | MP0005083_abnormal_biliary_tract | 0.67123215 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Thyroiditis (HP:0100646) | 4.18831865 |
| 2 | Mesomelia (HP:0003027) | 4.07006458 |
| 3 | Conjunctival hamartoma (HP:0100780) | 3.91867870 |
| 4 | Severe combined immunodeficiency (HP:0004430) | 3.75585697 |
| 5 | T lymphocytopenia (HP:0005403) | 3.66762513 |
| 6 | Fibular aplasia (HP:0002990) | 3.62746277 |
| 7 | Abnormality of T cell number (HP:0011839) | 3.48059112 |
| 8 | IgG deficiency (HP:0004315) | 3.32511731 |
| 9 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 3.28138316 |
| 10 | Short tibia (HP:0005736) | 3.24925850 |
| 11 | Hamartoma of the eye (HP:0010568) | 3.20356769 |
| 12 | Chronic diarrhea (HP:0002028) | 3.19130211 |
| 13 | Renal cortical cysts (HP:0000803) | 3.17285965 |
| 14 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.04981714 |
| 15 | Abnormality of the columella (HP:0009929) | 3.04528776 |
| 16 | Abnormality of eosinophils (HP:0001879) | 3.01688524 |
| 17 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.99806317 |
| 18 | Combined immunodeficiency (HP:0005387) | 2.85497035 |
| 19 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.79849310 |
| 20 | Volvulus (HP:0002580) | 2.77490879 |
| 21 | Nephronophthisis (HP:0000090) | 2.76639880 |
| 22 | Stomach cancer (HP:0012126) | 2.71580778 |
| 23 | Pendular nystagmus (HP:0012043) | 2.66667327 |
| 24 | Abolished electroretinogram (ERG) (HP:0000550) | 2.62305700 |
| 25 | Submucous cleft hard palate (HP:0000176) | 2.61409364 |
| 26 | Meningioma (HP:0002858) | 2.55864554 |
| 27 | Small hand (HP:0200055) | 2.55646881 |
| 28 | Pancreatic cysts (HP:0001737) | 2.53747681 |
| 29 | Abnormality of the renal cortex (HP:0011035) | 2.53623069 |
| 30 | Subacute progressive viral hepatitis (HP:0006572) | 2.52241153 |
| 31 | Median cleft lip (HP:0000161) | 2.50100702 |
| 32 | Furrowed tongue (HP:0000221) | 2.38940614 |
| 33 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.35708178 |
| 34 | Cavernous hemangioma (HP:0001048) | 2.33361775 |
| 35 | Hypoplasia of the thymus (HP:0000778) | 2.33018048 |
| 36 | Constricted visual fields (HP:0001133) | 2.32185412 |
| 37 | Asplenia (HP:0001746) | 2.31911312 |
| 38 | Persistence of primary teeth (HP:0006335) | 2.31245980 |
| 39 | Abnormality of T cells (HP:0002843) | 2.28633185 |
| 40 | Intestinal atresia (HP:0011100) | 2.24073937 |
| 41 | Abnormality of the renal medulla (HP:0100957) | 2.23904386 |
| 42 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 2.23534330 |
| 43 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.23272627 |
| 44 | Recurrent cutaneous fungal infections (HP:0011370) | 2.23272627 |
| 45 | Stomatitis (HP:0010280) | 2.21706127 |
| 46 | Angiofibromas (HP:0010615) | 2.21396073 |
| 47 | Adenoma sebaceum (HP:0009720) | 2.21396073 |
| 48 | Sensory axonal neuropathy (HP:0003390) | 2.20052159 |
| 49 | Anhidrosis (HP:0000970) | 2.11633095 |
| 50 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.10820944 |
| 51 | Attenuation of retinal blood vessels (HP:0007843) | 2.10145928 |
| 52 | Reduced antithrombin III activity (HP:0001976) | 2.06969843 |
| 53 | Congenital stationary night blindness (HP:0007642) | 2.03994044 |
| 54 | Abnormality of lateral ventricle (HP:0030047) | 2.03711608 |
| 55 | Conjugated hyperbilirubinemia (HP:0002908) | 2.02628912 |
| 56 | Molar tooth sign on MRI (HP:0002419) | 2.02220350 |
| 57 | Abnormality of midbrain morphology (HP:0002418) | 2.02220350 |
| 58 | Leukocytosis (HP:0001974) | 2.02203629 |
| 59 | Clubbing of toes (HP:0100760) | 1.99688355 |
| 60 | Pancreatic fibrosis (HP:0100732) | 1.99407438 |
| 61 | True hermaphroditism (HP:0010459) | 1.99266169 |
| 62 | Widely spaced teeth (HP:0000687) | 1.96688836 |
| 63 | Abnormal protein glycosylation (HP:0012346) | 1.96090903 |
| 64 | Abnormal glycosylation (HP:0012345) | 1.96090903 |
| 65 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.96090903 |
| 66 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.96090903 |
| 67 | Adrenal hypoplasia (HP:0000835) | 1.95607292 |
| 68 | Cupped ear (HP:0000378) | 1.95484746 |
| 69 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.92549564 |
| 70 | Hematochezia (HP:0002573) | 1.92532093 |
| 71 | Eosinophilia (HP:0001880) | 1.90883279 |
| 72 | 2-3 toe syndactyly (HP:0004691) | 1.90656375 |
| 73 | Clumsiness (HP:0002312) | 1.90242070 |
| 74 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.88842718 |
| 75 | Abnormality of the frontal sinuses (HP:0002687) | 1.88210815 |
| 76 | Neonatal respiratory distress (HP:0002643) | 1.86320297 |
| 77 | Bone cyst (HP:0012062) | 1.85211551 |
| 78 | Adactyly (HP:0009776) | 1.84956551 |
| 79 | Benign neoplasm of the central nervous system (HP:0100835) | 1.83913081 |
| 80 | Coxa valga (HP:0002673) | 1.83395408 |
| 81 | Paralysis (HP:0003470) | 1.82854438 |
| 82 | Abnormality of chromosome stability (HP:0003220) | 1.82358948 |
| 83 | IgA deficiency (HP:0002720) | 1.81782590 |
| 84 | Type I transferrin isoform profile (HP:0003642) | 1.81362785 |
| 85 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.80283881 |
| 86 | Hypothermia (HP:0002045) | 1.79269064 |
| 87 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.79225295 |
| 88 | Absent speech (HP:0001344) | 1.78928052 |
| 89 | Melanoma (HP:0002861) | 1.74583939 |
| 90 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.74442232 |
| 91 | Hypoplasia of the uterus (HP:0000013) | 1.74249223 |
| 92 | Anencephaly (HP:0002323) | 1.71973952 |
| 93 | Ovarian neoplasm (HP:0100615) | 1.71927431 |
| 94 | Protruding tongue (HP:0010808) | 1.70107513 |
| 95 | Duplicated collecting system (HP:0000081) | 1.69904679 |
| 96 | Abnormality of DNA repair (HP:0003254) | 1.69766534 |
| 97 | Abnormality of the renal collecting system (HP:0004742) | 1.69147933 |
| 98 | Hepatocellular carcinoma (HP:0001402) | 1.68474582 |
| 99 | Abnormality of the ileum (HP:0001549) | 1.65598209 |
| 100 | IgM deficiency (HP:0002850) | 1.64125145 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 4.40057820 |
| 2 | NME2 | 3.02196224 |
| 3 | FRK | 2.69311913 |
| 4 | PINK1 | 2.61326731 |
| 5 | FES | 2.57693749 |
| 6 | CSNK1A1L | 2.50344380 |
| 7 | NUAK1 | 2.32180181 |
| 8 | NEK9 | 2.21646266 |
| 9 | MST1R | 2.17769653 |
| 10 | TAOK3 | 2.16207882 |
| 11 | CSNK1G3 | 2.08854960 |
| 12 | ADRBK2 | 2.07194790 |
| 13 | NEK2 | 2.00007800 |
| 14 | NLK | 1.92971698 |
| 15 | ZAK | 1.92481681 |
| 16 | MAP2K7 | 1.88540141 |
| 17 | EIF2AK3 | 1.85455339 |
| 18 | CSNK1G1 | 1.82994986 |
| 19 | OBSCN | 1.72730635 |
| 20 | GRK1 | 1.71840409 |
| 21 | BMPR1B | 1.64213761 |
| 22 | MARK3 | 1.63715473 |
| 23 | ERBB3 | 1.62503121 |
| 24 | STK38L | 1.57666868 |
| 25 | CSNK1G2 | 1.50551076 |
| 26 | TGFBR2 | 1.37398283 |
| 27 | MAP4K2 | 1.37156479 |
| 28 | LATS1 | 1.35479875 |
| 29 | GRK6 | 1.34042899 |
| 30 | BLK | 1.28876260 |
| 31 | GRK7 | 1.24235084 |
| 32 | NEK1 | 1.20243351 |
| 33 | FER | 1.19572458 |
| 34 | BTK | 1.16885942 |
| 35 | STK4 | 1.14987401 |
| 36 | PRKCQ | 1.11764930 |
| 37 | TEC | 1.11173177 |
| 38 | SGK2 | 1.10318991 |
| 39 | WNK3 | 1.07569200 |
| 40 | CDK3 | 1.02594103 |
| 41 | ACVR1B | 1.01931217 |
| 42 | MAP3K4 | 0.98460694 |
| 43 | AKT3 | 0.96269879 |
| 44 | HCK | 0.92863208 |
| 45 | BRSK2 | 0.92763361 |
| 46 | SYK | 0.91274952 |
| 47 | IKBKB | 0.86933021 |
| 48 | PAK3 | 0.86152600 |
| 49 | SGK223 | 0.86142049 |
| 50 | SGK494 | 0.86142049 |
| 51 | IKBKE | 0.86122924 |
| 52 | TLK1 | 0.85847403 |
| 53 | TIE1 | 0.84532475 |
| 54 | MET | 0.82049739 |
| 55 | EIF2AK2 | 0.81335946 |
| 56 | TRPM7 | 0.80995901 |
| 57 | MOS | 0.80523761 |
| 58 | MAP3K6 | 0.80057686 |
| 59 | MAP3K2 | 0.79778263 |
| 60 | JAK1 | 0.76850894 |
| 61 | MAP3K14 | 0.76514335 |
| 62 | PIK3CG | 0.73957738 |
| 63 | STK3 | 0.72415933 |
| 64 | GRK5 | 0.71571283 |
| 65 | VRK1 | 0.67181213 |
| 66 | MAPK7 | 0.64460333 |
| 67 | MST4 | 0.62092125 |
| 68 | ZAP70 | 0.60016264 |
| 69 | BRD4 | 0.60016183 |
| 70 | TNIK | 0.59214266 |
| 71 | SGK3 | 0.58508932 |
| 72 | TYK2 | 0.57280560 |
| 73 | DAPK2 | 0.57056079 |
| 74 | MYLK | 0.56569212 |
| 75 | ADRBK1 | 0.55534621 |
| 76 | MELK | 0.53654802 |
| 77 | BCR | 0.53071650 |
| 78 | WEE1 | 0.52430719 |
| 79 | RPS6KA4 | 0.51749033 |
| 80 | PIM1 | 0.51541828 |
| 81 | CSNK1A1 | 0.49975176 |
| 82 | ITK | 0.48793715 |
| 83 | PRKAA2 | 0.47709609 |
| 84 | LYN | 0.45846221 |
| 85 | DYRK3 | 0.45810161 |
| 86 | RPS6KB1 | 0.43969237 |
| 87 | STK10 | 0.43346693 |
| 88 | PLK2 | 0.41909208 |
| 89 | MAP3K5 | 0.41609042 |
| 90 | IGF1R | 0.41264949 |
| 91 | JAK2 | 0.41091492 |
| 92 | EIF2AK1 | 0.40085549 |
| 93 | PIK3CA | 0.39826894 |
| 94 | WNK1 | 0.39681321 |
| 95 | CHUK | 0.38433990 |
| 96 | EGFR | 0.37919565 |
| 97 | TGFBR1 | 0.36475830 |
| 98 | MAPK13 | 0.35305237 |
| 99 | IRAK2 | 0.35277816 |
| 100 | STK38 | 0.35071804 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 3.52306731 |
| 2 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 3.15037990 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.95417442 |
| 4 | Phototransduction_Homo sapiens_hsa04744 | 2.75965525 |
| 5 | Basal transcription factors_Homo sapiens_hsa03022 | 2.51489323 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.35594858 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.34211617 |
| 8 | Circadian rhythm_Homo sapiens_hsa04710 | 2.28733462 |
| 9 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.22965206 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.20306348 |
| 11 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.16444158 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.02876186 |
| 13 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.97939984 |
| 14 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.86954011 |
| 15 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.85747815 |
| 16 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.81154834 |
| 17 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.79227505 |
| 18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.75318335 |
| 19 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.74422112 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.64456525 |
| 21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.61316719 |
| 22 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.60784047 |
| 23 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.46914640 |
| 24 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.44214281 |
| 25 | Proteasome_Homo sapiens_hsa03050 | 1.37988234 |
| 26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.36833682 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.34807519 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.34260706 |
| 29 | RNA degradation_Homo sapiens_hsa03018 | 1.33721208 |
| 30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.32919739 |
| 31 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.31830096 |
| 32 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.27575353 |
| 33 | Measles_Homo sapiens_hsa05162 | 1.23036992 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.20185831 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.18991641 |
| 36 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.14349625 |
| 37 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.12524048 |
| 38 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.09944654 |
| 39 | Taste transduction_Homo sapiens_hsa04742 | 1.03487454 |
| 40 | Homologous recombination_Homo sapiens_hsa03440 | 1.02421601 |
| 41 | Alcoholism_Homo sapiens_hsa05034 | 1.02323241 |
| 42 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.00556905 |
| 43 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.97526095 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.95095030 |
| 45 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.94415093 |
| 46 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.86825097 |
| 47 | Apoptosis_Homo sapiens_hsa04210 | 0.85898590 |
| 48 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85499766 |
| 49 | Hepatitis B_Homo sapiens_hsa05161 | 0.80324919 |
| 50 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.80217622 |
| 51 | Melanoma_Homo sapiens_hsa05218 | 0.79482809 |
| 52 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.78173990 |
| 53 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.76302844 |
| 54 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.75398129 |
| 55 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.74921463 |
| 56 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.74005971 |
| 57 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.73436451 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70777628 |
| 59 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.70701213 |
| 60 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.70654155 |
| 61 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.68177916 |
| 62 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.68114775 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67811142 |
| 64 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.67361022 |
| 65 | Renin secretion_Homo sapiens_hsa04924 | 0.64555651 |
| 66 | Salivary secretion_Homo sapiens_hsa04970 | 0.62889535 |
| 67 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.61375290 |
| 68 | Thyroid cancer_Homo sapiens_hsa05216 | 0.59666512 |
| 69 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.58505306 |
| 70 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.56899168 |
| 71 | Allograft rejection_Homo sapiens_hsa05330 | 0.55174726 |
| 72 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.54643201 |
| 73 | Asthma_Homo sapiens_hsa05310 | 0.54451168 |
| 74 | Influenza A_Homo sapiens_hsa05164 | 0.53867149 |
| 75 | Purine metabolism_Homo sapiens_hsa00230 | 0.52711933 |
| 76 | Peroxisome_Homo sapiens_hsa04146 | 0.50318349 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49475224 |
| 78 | Legionellosis_Homo sapiens_hsa05134 | 0.49191995 |
| 79 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.48411200 |
| 80 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.45116518 |
| 81 | RNA polymerase_Homo sapiens_hsa03020 | 0.44832786 |
| 82 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.43389997 |
| 83 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43132199 |
| 84 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.41483140 |
| 85 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.40908486 |
| 86 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.39496522 |
| 87 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.39375005 |
| 88 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.38368009 |
| 89 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.34857135 |
| 90 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.34794120 |
| 91 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.33998620 |
| 92 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33576913 |
| 93 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.31964309 |
| 94 | Lysine degradation_Homo sapiens_hsa00310 | 0.28780740 |
| 95 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.28258435 |
| 96 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.28221817 |
| 97 | ABC transporters_Homo sapiens_hsa02010 | 0.26636848 |
| 98 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.25170491 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.24996545 |
| 100 | Retinol metabolism_Homo sapiens_hsa00830 | 0.24477319 |

